CS logo
small CS logo
LLC Uromed

Smolensk, Russian Federation
Медицинская клиника в Смоленске

About LLC Uromed


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Arena Pharmaceuticals
2
Hoffmann-La Roche
2
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
1
Janssen Research & Development, LLC
1
Pfizer
1
Total Rows: 5

Clinical Trials at LLC Uromed


During the past decade, LLC Uromed conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 4 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years11222211110000001111Started TrialsCompleted Trails201720182019202020210123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Clinical Trial of Omalizumab in Participants With Chronic Rhinosinusitus With Nasal Polyps
2017-11-21
2019-03-07
Completed
127
A Study of Erdafitinib Compared With Vinflunine or Docetaxel or Pembrolizumab in Participants With Advanced Urothelial Cancer and Selected Fibroblast Growth Factor Receptor (FGFR) Gene Aberrations
2018-03-23
2024-04-26
Recruiting
631
An Extension Study of Omalizumab in Participants With Chronic Rhinosinusitis With Nasal Polyps
2018-05-09
2020-03-16
Completed
249
Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis
2019-06-13
2022-02-16
Completed
433
An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis
2019-09-05
2027-01-31
Recruiting
900
Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative Colitis
2020-09-15
2021-12-07
Completed
354
Study to Evaluate Efficacy, Immunogenicity and Safety of the Sputnik-Light
2021-02-19
2022-01-31
Unknown status
6,000

Rows per page:

1–7 of 7

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "LLC Uromed" #1 sponsor was "Arena Pharmaceuticals" with 2 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation" with 1 trials sponsored, "Janssen Research & Development, LLC" with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "LLC Uromed" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "CRO: iPharma" with 1 trials as a collaborator, "Government of the city of Moscow" with 1 trials as a collaborator and "Russian Direct Investment Fund" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.
Created with Highcharts 11.1.0Top Leading SponsorsArena Pharmaceuticals: 2Arena Pharmaceuticals: 2Hoffmann-La Roche: 2Hoffmann-La Roche: 2Gamaleya ResearchInstitute ofEpidemiology andMicrobiology, HealthMinistry of the RussianFederation: 1Gamaleya ResearchInstitute ofEpidemiology andMicrobiology, HealthMinistry of the RussianFederation: 1Janssen Research &Development, LLC: 1Janssen Research &Development, LLC: 1Pfizer: 1Pfizer: 1

Created with Highcharts 11.1.0Top CollaboratorsArena is a whollyowned subsidiary ofPfizer: 1Arena is a whollyowned subsidiary ofPfizer: 1CRO: iPharma: 1CRO: iPharma: 1Government of the cityof Moscow: 1Government of the cityof Moscow: 1Russian DirectInvestment Fund: 1Russian DirectInvestment Fund: 1

Clinical Trials Conditions at LLC Uromed


According to Clinical.Site data, the most researched conditions in "LLC Uromed" are "Ulcerative Colitis" (3 trials), "Chronic Rhinosinusitis" (2 trials), "Nasal Polyps" (2 trials), "COVID-19 Prevention" (1 trials) and "Urothelial Cancer" (1 trials). Many other conditions were trialed in "LLC Uromed" in a lesser frequency.

Clinical Trials Intervention Types at LLC Uromed


Most popular intervention types in "LLC Uromed" are "Drug" (6 trials), "Biological" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Etrasimod" (3 trials), "Omalizumab" (2 trials), "Docetaxel" (1 trials) and "Erdafitinib" (1 trials). Other intervention names were less common.

Clinical Trials Genders at LLC Uromed


The vast majority of trials in "LLC Uromed" are 7 trials for "All" genders.

Clinical Trials Status at LLC Uromed


Currently, there are NaN active trials in "LLC Uromed". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in LLC Uromed, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in LLC Uromed, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 7Phase 3: 7

Created with Highcharts 11.1.0Trials StatusCompleted: 4Completed: 4Recruiting: 2Recruiting: 2Unknown status: 1Unknown status: 1